|
Name |
(+)-(7S)-sydonic acid
|
Molecular Formula | C15H22O4 | |
IUPAC Name* |
3-hydroxy-4-[(2S)-2-hydroxy-6-methylheptan-2-yl]benzoic acid
|
|
SMILES |
CC(C)CCC[C@@](C)(C1=C(C=C(C=C1)C(=O)O)O)O
|
|
InChI |
InChI=1S/C15H22O4/c1-10(2)5-4-8-15(3,19)12-7-6-11(14(17)18)9-13(12)16/h6-7,9-10,16,19H,4-5,8H2,1-3H3,(H,17,18)/t15-/m0/s1
|
|
InChIKey |
VZXPWVDKXCYHSI-HNNXBMFYSA-N
|
|
Synonyms |
S-Sydonic acid; Sydonic acid; Sydonic acid, (S)-; (S)-(+)-Sydonic acid; (+)-(7S)-sydonic acid; RVU8KTT150; CHEBI:68223; 1137089-32-7; 3-Hydroxy-4-((1S)-1-hydroxy-1,5-dimethylhexyl)benzoic acid; Benzoic acid, 3-hydroxy-4-((1S)-1-hydroxy-1,5-dimethylhexyl)-; 3-Hydroxy-4-[(1S)-1-hydroxy-1,5-dimethylhexyl]benzoic acid; UNII-RVU8KTT150; MLS003373246; CHEMBL2361427; DTXSID601192492; ZINC13482266; SMR002048003; Q27136716; (S)-3-hydroxy-4-(2-hydroxy-6-methylheptan-2-yl)benzoic acid; 3-hydroxy-4-[(2S)-2-hydroxy-6-methylheptan-2-yl]benzoic acid
|
|
CAS | 1137089-32-7 | |
PubChem CID | 25775004 | |
ChEMBL ID | CHEMBL2361427 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 266.33 | ALogp: | 3.6 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 77.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 19 | QED Weighted: | 0.729 |
Caco-2 Permeability: | -4.706 | MDCK Permeability: | 0.00001730 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.012 |
Blood-Brain-Barrier Penetration (BBB): | 0.129 | Plasma Protein Binding (PPB): | 75.98% |
Volume Distribution (VD): | 0.328 | Fu: | 30.78% |
CYP1A2-inhibitor: | 0.092 | CYP1A2-substrate: | 0.48 |
CYP2C19-inhibitor: | 0.04 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.307 | CYP2C9-substrate: | 0.195 |
CYP2D6-inhibitor: | 0.024 | CYP2D6-substrate: | 0.106 |
CYP3A4-inhibitor: | 0.069 | CYP3A4-substrate: | 0.094 |
Clearance (CL): | 4.184 | Half-life (T1/2): | 0.845 |
hERG Blockers: | 0.05 | Human Hepatotoxicity (H-HT): | 0.313 |
Drug-inuced Liver Injury (DILI): | 0.867 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.114 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.083 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.011 | Eye Irritation: | 0.755 |
Respiratory Toxicity: | 0.049 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004442 | 0.776 | D0BA6T | 0.328 | ||||
ENC005624 | 0.776 | D05VIX | 0.324 | ||||
ENC003302 | 0.729 | D0P7JZ | 0.314 | ||||
ENC002383 | 0.700 | D02ZJI | 0.301 | ||||
ENC002565 | 0.700 | D0K5CB | 0.301 | ||||
ENC002688 | 0.695 | D08HVR | 0.299 | ||||
ENC002474 | 0.690 | D0Y6KO | 0.297 | ||||
ENC005625 | 0.515 | D0C4YC | 0.295 | ||||
ENC005622 | 0.507 | D01WJL | 0.295 | ||||
ENC005623 | 0.507 | D06GIP | 0.295 |